UK markets closed

Kala Pharmaceuticals, Inc. (KALA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
7.97+0.12 (+1.53%)
At close: 03:59PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
3,892
11,240
6,362
Cost of revenue
0
2,560
4,097
3,173
Gross profit
0
1,332
7,143
3,189
Operating expenses
Research development
17,191
17,653
11,515
18,352
Selling general and administrative
21,775
65,035
105,061
81,068
Total operating expenses
35,996
82,688
116,576
99,420
Operating income or loss
-35,996
-81,356
-109,433
-96,231
Interest expense
5,923
7,266
8,380
8,589
Total other income/expenses net
-6,951
43,136
-24,896
-
Income before tax
-46,415
-44,822
-142,605
-104,327
Income from continuing operations
-46,415
-44,822
-142,605
-104,327
Net income
-46,415
-44,822
-142,605
-104,327
Net income available to common shareholders
-46,415
-44,822
-142,605
-104,327
Basic EPS
-22.38
-29.48
-108.32
-99.50
Diluted EPS
-22.38
-29.48
-108.32
-99.50
Basic average shares
2,156
1,521
1,316
1,048
Diluted average shares
2,156
1,521
1,316
1,048